| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6e155fbc4f5769ab6553686affb39af |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2014-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06467c45f9aba450fe6546856dfd2a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_989e949a8fbfb9c3827f0508610874c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebe50308d42f51419c3016687f236af7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_900145012b03b491de09f9aaac3ff098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14a6f9a9f8d8e99eddb47bdf91b12021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ebc321e8d5671db7d5a017b1286a6a2 |
| publicationDate |
2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3052088-A2 |
| titleOfInvention |
Medical composition containing a cholesterol absorption inhibitor and cholesterol biosynthesis inhibitor |
| abstract |
The present invention is related to a pharmaceutical composition containing rosuvastatin and ezetimibe, wherein the interaction of the active ingredient and excipient is minimized, the active ingredients are present in spatially separated or contacting physical phases and wherein the active ingredient release from the two phases takes place in temporarily separated manner rather than occuring at the same time or begins delayed from one phase compared to the other, other. A further aspect of the present invention is method for decreasing an active ingredient- excipient interaction or interaction between active ingredients in combined pharmaceutical composition containing several solid phases produced by compression, which comprises adjusting the disintegration time of the compressed solid phases different from each other. |
| priorityDate |
2013-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |